You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

 

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

AbstractFullPdf
Jun 2022592599245
Jul 2022379389173
Aug 202224825278
Sep 202224024363
Oct 202222422558
Nov 202217417551
Dec 202215415441
Jan 202316216336
Feb 202316616862
Mar 202314114246
Apr 202313613651
May 202315115247
Jun 2023747424
Jul 2023696939
Aug 2023636428
Sep 2023707224
Oct 2023707134
Nov 2023868627
Dec 2023787931
Jan 2024596129
Feb 2024585834
Mar 2024595960
Total345334911281